WRN helicase defective in the premature aging disorder
                        Werner syndrome genetically interacts with topoisomerase 3 and restores the









































Understanding the genetic pathways of the WRN 
helicase-exonuclease has posed a complex challenge to 
researchers.  Studies of WRN-deficient cell lines have 
provided evidence for a role of WRN in the response to 
replicational stress through a recombinational repair 
pathway [1, 2]; however, the precise molecular 
functions and protein interactions required for WRN to 
help cells proliferate, maintain genomic stability, and 
deal with endogenous or exogenously induced DNA 
damage are not well understood.  Moreover, although 
the clinical and cellular phenotypes of Werner 
Syndrome (WS)  appear to  be distinct  from that of   the  
 
 








































































other human RecQ helicase disease, it is not clear if 
WRN has entirely unique or at least partially 
overlapping roles with the other RecQ helicases to 
maintain genomic stability (for review, see [3, 4]).   
 
To investigate the genetic functions of WRN in a 
defined setting, we have developed a yeast-based model 
system to study the functional requirements of WRN in 
pathways that are conserved between yeast and human.  
Unlike human cells which have five RecQ helicases 
(WRN, BLM, RECQ1, RECQ5, and RECQ4), 
Saccharomyces cerevisiae has only a single RecQ 
homolog, Sgs1 [4].  Although sgs1 mutants exhibit 
sensitivity to DNA damaging agents or replication 
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known genetic function of sgs1 is to suppress the slow 
growth phenotype of a top3 mutant.  It is believed that 
Top3 decatenates intertwined DNA molecules 
generated by Sgs1 helicase during replication [5, 6]; 
therefore, in the absence of Top3, torsional stress is not 
relieved resulting in slow growth and hyper-
recombination.  Based on the genetic and physical 
interaction of Sgs1 with Top3 [5, 7, 8], a model has 
been proposed that together they suppress the formation 
of cross-over products that arise from the resolution of 
Holliday Junction (HJ) recombination intermediates [9, 
10].  Conserved interactions between RecQ helicases 
and Top3 exist in other organisms as well [11-15]. 
 
In human cells, BLM physically interacts with Top3α, 
and  the two proteins together have the ability to 
catalyse double HJ dissolution on model DNA 
substrates in a reaction that requires BLM-mediated 
ATP hydrolysis and the active-site tyrosine residue of 
Top3α [16].  This reaction gave rise exclusively to non-
cross-over products, as predicted from the hemicatenane 
model, and supports a proposed role of BLM with 
Top3α as a suppressor of sister chromatid exchanges 
(SCEs).  RMI1 (BLAP75) promotes this BLM-
dependent dissolution of the homologous recombination 
(HR) intermediate by recruiting Top3α to the double HJ 
[17, 18].  Interestingly, BLM appears to be unique in 
the double HJ dissolution reaction since WRN, RECQ1 
and RECQ5 all failed to substitute for BLM [17, 19].  
Moreover, association of Top3α and BLAP75 with 
BLM stimulates its HJ unwinding activity; however, 
neither WRN nor E. coli RecQ HJ unwinding was 
stimulated by Top3α BLAP75 [20].  Very recently, a 
new component of the BLM-Top3α complex, 
designated RMI2, was identified that is important for 
the stability of the BLM protein complex [21, 22].   
RMI2 deficiency in vertebrate cells results in 
chromosomal instability [21, 22], suggesting its 
function as a tumor suppressor.  RMI2 enhanced the 
double HJ dissolvase activity of the BLM-Top3α 
complex [21], indicating that additional proteins are 
likely to be involved.  In fact, other proteins were 
isolated with the RMI2 complex, including the 
mismatch repair complex MSH2/6, RPA, and the 
Fanconi Anemia proteins FANCM and FAAP24 [21].   
 
The suppression of recombinant cross-over products 
that are detected as sister chromatid exchanges is 
thought to be specific to the coordinate functions of 
yeast Sgs1 and Top3, and its human counterparts, BLM 
and Top3α However, RECQ5 and RECQ1 also interact 
with Top3α  [23, 24], and elevated SCE is also found in 
fibroblasts from RECQ5 [25] or RECQ1 [26] knockout 
mice as well as human cells depleted of RECQ1 by 
RNA interference [27].  These studies suggest that 
RecQ helicases participate in non-redundant pathways 
to suppress cross-overs during mitosis [28]. 
 
WS cells have a unique form of genomic instability 
known as variegated translocation mosaicism, charac-
terized by extensive deletions and rearrangements [29].  
WS cells, like other RecQ mutants, are also defective in 
recombination and sensitive to DNA damaging agents 
[3, 30].  To begin to understand the basis for these 
defects in cellular DNA metabolism, we tested the 
ability of WRN in defined genetic backgrounds using 
yeast as a model system.  Using this approach, we 
discovered that WRN restores the top3 slow growth 
phenotype in the sgs1 top3 background, but does not 
complement the DNA damage sensitivity or growth of a 
single sgs1 mutant.  WRN helicase activity is required 
for genetic restoration of the top3 growth phenotype, 
suggesting that WRN unwinding activity creates a DNA 
substrate in vivo that in the absence of top3 prevents 
normal cell growth.  These results have implications for 
the potentially overlapping pathways between RecQ 
helicases, particularly WRN and the human homolog of 
Sgs1, BLM.  Moreover, depending on the genetic 
background, recombinational events initiated or 
mediated by WRN helicase activity may have 




Expression of the human Werner syndrome protein 
(WRN) in yeast fails to rescue the 
methylmethanesulfonate or hydroxyurea 
hypersensitivity of an sgs1 mutant 
 
The  sgs1 strain is characterized by sensitivity to the 
compound methylmethanesulfonate (MMS), which 
introduces alkylation base damage or to hydroxyurea 
(HU), a replication inhibitor.  To assess the effect of 
WRN expression on the MMS or HU-sensitivity 
phenotype of the sgs1 mutant, sgs1 was transformed with 
a multi-copy TRP1 selectable plasmid which is either 
empty or encoding full-length WRN protein (1-1432).   
Quantitative Western blot analyses using purified 
recombinant WRN protein as standard indicated that 8.1 
x 104 WRN molecules/cell were present at 2% galac-
tose (gal) concentration (data not shown).   In compa-
rison, the level of endogenous WRN in HeLa cells was 
determined to be  8.9 x 104  molecules/cell [31], in 
agreement with published values for WRN copy 
number in other human cells [32, 33].  Therefore, the 
level of WRN protein expression in yeast is comparable 
to that in human cells and considered physiological.   
The sgs1 strain transformed  with empty vector  (sgs1/ 
   























/vector) did not express
 protein specifically recognized 
by WRN antibody (data not shown).  Transformed sgs1 
cells were serially diluted and spotted on to a synthetic 
complete (SC) 2% gal media lacking tryptophan (Trp) 
and containing the indicated concentration of either 
MMS or HU.  As shown in Figure 1, WRN failed to 
rescue the sensitivity of the sgs1  mutant to MMS or 
HU, and was observed to enhance the sensitivity of sgs1 
to either drug.  The vector-transformed wild-type parent 
strain (W3031A) was included as a control, showing 
resistance to MMS or HU (Figure 1).  The wild-type 
parent strain transformed with the YEp112SpGAL-
WRN plasmid (Wild type/WRN) showed MMS and HU 
resistance comparable to Wild type/Vector (Figure 1), 
indicating that the drug sensitivity was dependent on the 
sgs1 mutation.  Similar results were obtained at lower 
WRN protein levels induced by 0.5% gal (Supp. Data 
Figure 1). 
 
WRN and TOP3 genetically interact  
 
Strains mutant for top3 have pleiotropic phenotypes 
including severe growth defect, hyper-recombination at 
multiple loci, and sensitivity to the DNA damaging 
agents MMS and HU.  However, a mutation in the sgs1 
gene suppresses the slow growth rate of top3 [5].  Since 
it has been proposed that Top3 may be an evolutionarily 
conserved partner of RecQ helicases, we examined if 

































hence confer slow growth in the sgs1 top3 background.   
sgs1 top3 double mutant cells transformed with 
YEp112SpGAL or YEp112SpGAL–WRN were 
streaked onto plates containing SC minus Trp media 
with 2% gal.  As shown in Figure 2A, the WRN 
transformed sgs1 top3 strain grew significantly slowly 
compared to the vector transformed sgs1 top3 strain.   
sgs1 top3 transformed with the YEp112SpGAL-SGS1 
plasmid was included as a positive control (Figure 2A), 
demonstrating that wild-type Sgs1 expressed in the sgs1 
top3 mutant was able to genetically complement the 
growth phenotype.  The transformed sgs1 top3 strains 
grew similarly in the absence of gal as shown for 2 days 
(Figure 2A) or earlier time points (data not shown).   
Expression of WRN had no effect on the growth of 
parental wild-type (W3031A) or sgs1 strains (Figure 
2B), indicating that the effect of WRN on cell growth 
was specific to that observed in the sgs1 top3 mutant 
background.  
 
To further evaluate the effect of WRN expression on 
growth of the sgs1 top3 double mutant, liquid culture 
experiments were performed.  After an initial lag phase 
for all cultures, sgs1 top3/WRN exhibited decreased 
growth compared to sgs1 top3/vector, evident at 12, 16, 
and 20 hr (Figure 2C).  The decrease in cell growth for 
the sgs1 top3/WRN cells was not quite as great as that 
observed for sgs1 top3/SGS1, suggesting a partial resto-




   










































WRN expression alters the cell cycle distribution of 
sgs1 top3 
 
It was previously shown that top3 mutant strains are 
delayed in the late S/G2 phase of the cell cycle [5], a 
characteristic that may account for their slow growth.  
Mutation of the SGS1 gene in the top3 background 
suppresses the delay in the S/G2 phase of the cell cycle; 
consequently, the characteristic dumb-bell shaped 
morphology of the top3 mutant yeast cells that have not 























































tion.  We examined if WRN expression could restore 
the delay in the S/G2 phase of the cell cycle in sgs1 
top3.  An elevated population of large budded cells with 
undivided nuclei was observed for the sgs1 top3 mutant 
cells expressing WRN (Figure 3).  The percentage of 
sgs1 top3/WRN cells with dumb-bell morphology was 
approximately 2.6-fold greater than that of sgs1 
top3/vector cells, suggesting that WRN expression in 
the  sgs1 top3 mutant restored the characteristic S/G2 
delay of top3 and this may contribute to the suppression 
of growth by WRN in the sgs1 top3 cells. 
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required to restore the top3 slow growth phenotype 
 
To assess the functional requirements of WRN to 
restore the slow growth phenotype in the sgs1 top3 
background, we assessed the importance of WRN 
catalytic activities (helicase, exonuclease) for slow 
growth phenotype restoration. To do this, we 
constructed WRN expression plasmids containing 
missense point mutations in the active site of the 
conserved exonuclease domain (E84A) or the 
ATPase/helicase domain (K577M) that were previously 
shown to inactivate the respective catalytic activities of 
the purified recombinant proteins [34, 35] (Figure 4A).  
Plasmids encoding the WRN mutant alleles were 
transformed into the sgs1 top3 cells and expression of 






































blot analyses (Figure 4B).  The effects of mutant WRN 
protein expression on growth were assessed by 
streaking the transformed yeast strains onto SC plates 
media with 2% gal but lacking Trp.  Streak analysis 
revealed that the WRN-E84A exonuclease dead mutant 
restored the top3-associated slow growth phenotype in 
sgs1 top3 comparable to wild-type WRN, whereas the 
WRN-K577M ATPase/ helicase dead mutant failed to 
restore the slow growth in the sgs1 top3 as shown by its 
similar level of growth to that of the sgs1 top3/vector 
cells (Figure 4D).  However, the sgs1 top3/WRN-E84A 
and sgs1 top3/WRN-K577M cells grew equally well in 
the absence of gal induction (Figure 4E).  From these 
results, we conclude that WRN helicase but not 
exonuclease activity was required for restoration of 
















































   
































Genetic analysis of a naturally occurring WRN 
missense polymorphism or engineered RQC domain 
WRN missense mutant in the sgs1 top3 background  
 
In addition to the helicase domain, many RecQ 
helicases share another conserved sequence C-terminal 
to the ATPase/helicase core domain designated the 
RecQ C-terminal (RQC) region that has been implicated 
in DNA binding and protein interactions [4].  To 
address the potential importance of the WRN RQC 
domain for its biological function, we examined the 
ability of a specific WRN RQC missense mutant, 
WRN-K1016A (Figure 4A), to restore the slow growth 
phenotype of top3 in sgs1 top3.  The WRN-K1016A 
mutant was previously characterized and shown to have 
significantly reduced DNA binding and helicase activity 
compared to the wild-type recombinant WRN protein 
[36].  sgs1 top3 expressing WRN-K1016A (Figure 4B) 
grew similarly to the sgs1 top3/vector cells (Figure 4D), 
indicating that expression of the WRN-K1016A mutant 
failed to restore the slow growth phenotype charac-


































in  sgs1  top3  background.  Panel  A,  WRN  protein  with  conserved  domains  and  positions  of  site‐directed  mutations.    Panel  B,
Expression of WRN and WRN variants in transformed sgs1 top3 was induced at 2% gal concentration and cells were harvested after 6 h.
Equal  amount  of  total  cell  lysate  was  loaded  on  to  8‐16%  polyacrylamide  SDS  gels,  followed  by  Western  blotting  using  anti‐WRN
antibody.   sgs1 top3 strain transformed with ATPase/helicase‐dead (YEp195SpGAL–WRN K577M), exonuclease‐dead (YEp195SpGAL‐
WRN E84A), RQC mutant (YEp195SpGAL‐WRN K1016A), or polymorphic mutant (YEp195SpGAL‐WRN R834C) was streaked on SC‐Trp
plates  containing  either  2%  glu  (Panel  E)  or  2%  gal  (Panel  D).  Plates  were  incubated  at  30°C  for  2 days  and  then  photographed.
Composition of the plates was as in Panel C. 
 
Although no missense mutations have been identified 
that are genetically linked to Werner syndrome, a 
number of WRN polymorphic missense variants exist 
whose biological significance is not well understood.   
The lack of genetic data on WRN polymorphisms 
suggested to us that the yeast-based WRN system might 
be useful in their analysis.  The WRN-834C polymer-
phism residing in the core helicase domain was
 
identified in DNA from the Polymorphism Discovery 
Resource database (egp.gs.washington.edu) (Figure 
4A).  Previously, it was reported by the Loeb lab that 
the purified recombinant WRN-R834C protein has 
dramatically reduced WRN ATPase, helicase, and 
helicase-coupled exonuclease activity [37].  To assess 
the biological effect of the WRN R834C polymorphic 
change, sgs1 top3/WRN-R834C was streaked onto a SC 
plate lacking Trp and containing 2% gal.  Expression of 
WRN-R834C (Figure 4B) demonstrated comparable 
growth to that of sgs1 top3/vector (Figure 4D).  These 
results demonstrate that the WRN-R834C poly-
morphism, similar to the K577M and K1016A 
mutations that interfere with WRN helicase activity, 
   




 have shown that gene expression levels 
from the GAL1/10 promotor
 can be regulated by altering 
the concentration of gal in the
  growth medium.  We 
therefore examined the level of WRN
 protein expression 
in cells grown at lower gal concentrations
 (0–2%) in the 
presence of 2% raffinose (raf).  Western blot
  analyses 
demonstrated that WRN expression was dependent on the 
concentration of gal in the media (Figure 5A).   
Quantitative
  Western blot analyses using purified 
recombinant WRN protein as standard indicated that 2.3 
x 10
4 WRN molecules/cell were present at 2% gal.  As 
WRN expression was regulated by the level of gal, we
 
wanted to compare the ability of WRN and its associated 
variants to restore the slow growth phenotype of top3 in 





































sion.  WRN restored the slow growth phenotype of sgs1 
top3 throughout the gal concentration range, including 
the lower gal concentrations (Figure 5C-F).  Similarly, 
WRN-E84A mutant restored the slow growth top3 
phenotype, whereas the ATPase/ helicase dead WRN-
K577M mutant failed to do so (Figure 5C-F).  Likewise, 
neither WRN-R834C nor WRN-K1016A affected the 
growth of the sgs1 top3 mutant (Figure 5C-F).  No effect 
on the growth rate of wild-type parental strain (W3031B) 
as well as sgs1 strain was observed with WRN or its 
associated variants (Supp. Data Figures 2 and 3).  These 
results demonstrate that wild-type WRN or the WRN 
exonuclease dead proteins are similarly able to restore the 
top3 growth phenotype in the sgs1 top3 background, 
whereas the WRN mutant proteins that have defective 
ATPase/helicase activity did not affect the growth of the 
sgs1 top3 mutant at either low or high levels of gal-















































   




































Effect of WRN expression on the MMS and HU 
sensitivity of the sgs1 top3 mutant 
 
Previously, it was reported that the sgs1 top3 double 
mutant is less sensitive to MMS or HU than the top3 
single mutant [6].  Since WRN affected cell growth of 
sgs1 top3, we next examined its effect on drug 
sensitivity.  As shown in Figure 6, sgs1 top3/WRN 
displayed sensitivity to both MMS and HU that was 
comparable to sgs1 top3/SGS1, whereas  sgs1 
top3/vector was more resistant to either drug.  Genetic 
analysis of the WRN variants in the sgs1 top3 back-
ground revealed that strains transformed with WRN-

















































sensitivity comparable to that of vector, whereas the 
sgs1 top3/WRN-E84A strain showed HU and MMS 
resistance similar to sgs1 top/WRN and sgs1 top3/SGS1 
(Figure 6).  These results demonstrate that in addition to 
its effect on growth in the sgs1 top3 background, WRN 
also affects sensitivity of the sgs1 top3 mutant to HU or 
MMS.  Furthermore, WRN ATPase/helicase but not 
exonuclease activity is genetically required for its effect 
on HU or MMS sensitivity in the sgs1 top3 background.  
Expression of WRN in the wild-type parent strain had 
no effect on the strain’s sensitivity to the tested 
concentration of HU or MMS (Supp. Data Figure 4), 
indicating that the effect of WRN expression was 
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From our studies, we conclude that WRN genetically 
interacts with Top3 through its ability to restore the 
top3 slow growth phenotype in the sgs1 top3 
background.  WRN helicase activity is required for 
genetic restoration of slow growth, similar to previous 
studies which demonstrate that sgs1 helicase defective 
alleles fail to suppress top3 slow growth [38, 39].   
Although WRN suppressed the growth in the sgs1 top3 
double mutant, WRN did not rescue the sensitivity of 
sgs1 to the DNA damaging agent MMS or the 
replication inhibitor HU.  Thus, WRN cannot directly 
replace the Sgs1 helicase in the cellular response to 
replicational stress.  However, in a pathway defined by 
genetic background, human WRN expressed in yeast 
can clearly exert a phenotype.  The ability of WRN to 
affect the growth phenotype in the sgs1  top3 
background is supported by our observation that the 
morphological appearance of large budded cells with 
undivided nuclei characteristic of S/G2 arrest is restored 
in the WRN-transformed sgs1 top3 mutant.  This work 
is the first demonstration that WRN can function in a 
genetic pathway that affects top3-related  phenotypes, 
and this role is dependent on WRN helicase but not 
exonuclease activity.  
    
Previous studies demonstrated that expression of WRN 
or BLM in sgs1 does not affect growth rate, but can 
partially suppress illegitimate recombination or 
homologous recombination [40].  However, a distinc-
tion in the biological functions between the two human 
RecQ helicases was suggested based on the observation 
that expression of BLM, but not WRN, can restore the 
resistance of the sgs1 mutant to the replication inhibitor 
HU [40] and extend the shortened lifespan caused by 
the sgs1 mutation [41].  It was also reported that human 
BLM, but not WRN, can suppress the growth in the 
sgs1 top3 double mutant [40], suggesting that yeast 
Sgs1 helicase has functions similar to those of human 
BLM helicase.  Although we also observed that WRN 
expression failed to correct the HU sensitivity of the 
sgs1 mutant, we found that WRN expression can restore 
the  top3 slow growth phenotype in the sgs1 top3 
background.  The difference between our study and the 
earlier one may reflect differences in WRN protein 
expression (since the earlier study did not report a 
quantitative level of WRN protein), strains, or yeast 
culture conditions.  Our quantitative Western blot 
analyses demonstrate that WRN expressed in yeast at 
levels comparable to that previously reported in several 
human cell lines was sufficient to restore growth in the 
sgs1 top3 mutant as detected by plate streak studies or 
liquid culture growth analysis.  From these results, we 
conclude that WRN can function in the sgs1 top3 
background, indicating some genetic overlap between 
the WRN and Sgs1 pathways.  By inference, WRN may 
also have overlapping genetic functions with BLM.   
Although WRN was not observed in vitro to substitute 
in the BLM- Top3α complex double HJ dissolution 
reaction (see Introduction), it is plausible that WRN 
interacts with Top3α in a related protein complex with 
additional factors and can perform a function important 
for genomic stability.  The results from our sgs1 top3 
WRN complementation studies in yeast prompt further 
investigation of the possibility that WRN functionally 
interacts with Top3α in human cells during cellular 
DNA replication or recombination.  Conceivably, in a 
BLM-impaired condition, WRN may partially substitute 
for BLM through its protein partnership with a 
topoisomerase. 
 
In a previous study, we found that human WRN 
expressed in a yeast dna2-1  mutant background can 
rescue the associated replication and repair phenotypes; 
however, a non-catalytic C-terminal domain of WRN 
was sufficient for genetic rescue, demonstrating that 
WRN helicase activity is not required to rescue the 
mutant cellular phenotypes associated with the dna2-1 
mutant [31].  Based on genetic and biochemical results, 
the explanation for this finding was that WRN rescues 
the dna2-1 mutant by interacting with endogenous yeast 
Flap Endonuclease-1 (FEN-1) and stimulating its 
nuclease activity, thereby bypassing the requirement for 
wild-type DNA2 nuclease to process DNA replication 
and repair intermediates [31, 42].  In contrast, we show 
in the current study that WRN helicase activity is 
required to suppress growth in the sgs1 top3 mutant.  
The distinct genetic requirements for WRN to rescue 
different mutant backgrounds suggest that WRN can 
operate in separate pathways using different catalytic or 
protein interaction domains.  We propose that WRN is a 
modular pleiotropic protein with unique catalytic or 
protein interaction domains that are necessary to fulfill 
its functions in different biological settings dictated by 
mutant genetic background.   
 
In addition to the yeast studies which have examined 
the genetic interactions between sgs1 and top3, the 
potential functional overlap of Sgs1 with other topo-
isomerases has been investigated.  For example, sgs1 
top1 mutants are severely growth impaired, suggesting 
that the synergistic defect can be attributed to the two 
genes operating in separate but overlapping pathways.  
This is distinct from the epistatic relationship of sgs1 
and top3.  Based on their genetic findings, Weinstein 
and Rothstein proposed that a subset of DNA structures 
which arise at stalled or collapsed replication forks 
normally processed by the Sgs1-Top3 pathway can be 
alternatively channeled into a Top1-dependent pathway 
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conceivable that WRN, which interacts physically and 
functionally with human TOP1 [43], may collaborate 
with Top1 (or another topoisomerase) in yeast to 
generate a viable but poorly growing cell in a pathway 
parallel to Sgs1.  Alternatively, WRN may directly 
substitute for Sgs1 only in a specialized situation when 
Top3 is absent.  It is conceivable that the poor growth of 
the  top3 mutant is attributed to unresolved 
recombinogenic DNA intermediates created by WRN 
helicase activity.  This last idea underscores a growing 
notion in the field that genetic recombination must be 
properly regulated; otherwise, deleterious recombi-
nation events acting on aberrant DNA structures prevail 
[44].  Thus, RecQ helicase-mediated recombination 
pathways are like a double-edged sword.  In the 
appropriate genetic background, these pathways secure 
a normal growth rate and genomic stability; however, in 
certain mutant backgrounds (e.g., top3), DNA 
unwinding by a RecQ helicase is counter-productive to 
cell growth and genome homeostasis.       
 
MATERIALS AND METHODS 
 
Plasmid DNA constructs.  Site-directed mutations of 
WRN (E84A, K577M, R834C, and K1016A) in the 
plasmid YEp195SpGAL-WRN [31]  were constructed 
using mutagenic primers (Supp. Data Table 1) and a 
standard protocol from Quickchange II XL site-directed 
mutagenesis kit (Stratagene) by Lofstrand labs 
(Gaithersburg, MD).  DNA fragments encoding WRN 
and its associated variants were gel purified from the 
respective YEp195SpGAL-WRN constructs after 
double digestion with SalI and MluI.  Gel purified 
fragments were then cloned into the SalI–MluI
 sites of 
vector YEp112SpGAL [45], a 2 µm multi-copy
 plasmid 
containing a TRP1 selectable marker to construct 
YEp112SpGAL–WRN
  or WRN variants under the 
control of
  a gal-inducible promotor.  The SGS1 
expression plasmid pSGS1f2 was kindly provided by 
Dr. Brad Johnson (University of Pennsylvania School of 
Medicine, Philadelphia, Pennsylvania).  SGS1 was PCR 
amplified using  5’-ACGCGTCGACATGGTGACGAA 
GC-3’ and 5’-GTCTCCTTCACTACGCGTCGAAT-3’ 
as the forward and the reverse primers, respectively, 
using pSGS1f2 as a template. PCR was carried out with 
PCR super mix HiFi (Invitrogen) for 30 cycles 
(denaturation at 94°C for 30 s per cycle, annealing at 
57°C for 50 s per cycle, and elongation at 72°C for 5 
min per cycle).  The amplified product was cloned into 
the SalI–MluI
 sites of vector YEp112SpGAL. 
 
Yeast media and strains.  Strains with wild-type SGS1 
TOP3  (WT; W303-1A, genotype, MATa ade2-1 canl- 
100 his3-11,15 leu2-3,112 trpl-l ura3-1) [5], a sgs1 
mutant (W1292-3C; genotype MATa  SUP4-o::URA3 
sgs1-25 ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 
ura3-1 rad5-535) and a sgs1 top3 mutant ( W1058-11C, 
genotype, MATa SUP4-o::URA3 sgs1-25 top3-2::HIS3 
ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 
rad5-535) have been characterized [6] and were kindly 
provided by Dr. Rodney Rothstein (Columbia 
University).  Yeast cultures were grown using standard 
protocol and transformations were performed using a 
Lithium Acetate-based protocol [46].  Transformed 
yeast strains were grown in SC media minus Trp and 
containing either glucose (glu) or gal as required. 
 
Genetic analysis of hydroxyurea or methylmethane-
sulfonate sensitivity in WRN transformed yeast strains.  
To determine the effect of WRN expression on the 
MMS and HU sensitivity of sgs1 or sgs1 top3 strains, 
strains transformed with YEp112SpGAL or 
YEp112SpGAL-WRN were grown in SC raf minus Trp 
at 30
oC.  Cultures were reinocula-ted in SC raf minus 
Trp and grown at 30°C to early log phase (OD600 of 
~0.6 to 0.8).  Ten-fold serial dilutions of these strains 
were spotted onto SC gal minus Trp plates containing 
the indicated concentrations of HU or MMS.  Plates 
were incubated at 30°C.  As a control, wild-type 
parental strain (W303-1A) transformed with 
YEp112SpGAL or YEp112SpGAL-WRN, or sgs1 top3/ 
YEp112SpGAL-SGS1 was treated as described above.   
 
Genetic analysis of the slow growth phenotype in WRN 
transformed sgs1 top3 strain. To examine the effect of 
WRN expression on the growth of wild-type parental 
(W303-1A),  sgs1, or sgs1 top3 strains, the 
corresponding strains transformed with YEp112SpGAL 
or YEp112SpGAL-WRN were streaked onto SC minus 
Trp plates containing either glu or gal as indicated.  As 
a control, sgs1 top3/YEp112SpGAL-SGS1 was 
included. Plates were incubated at 30°C.  To determine 
the ability of WRN to affect growth rate of sgs1 top3 
strain at lower WRN protein expression levels, the sgs1 
top3 strain transformed with YEp112SpGAL, 
YEp112SpGAL-WRN, or YEp112SpGAL-SGS1 was 
streaked onto SC minus Trp plates containing varying 
concentrations of gal as indicated. 
 
To assess the functional requirements of WRN to restore 
the slow growth phenotype in the sgs1top3 background, 
sgs1 top3 transformed with YEp112SpGAL-WRN 
(E84A, K577M, R834C, and K1016A) were streaked 
onto SC minus Trp plates containing either glu or gal as 
indicated.  For controls, sgs1 top3 strain transformed with 
YEp112SpGAL,  YEp112SpGAL-WRN  or  YEp112Sp 
GAL-SGS1 was included. 
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in liquid culture, yeast cells were grown in SC raf minus 
Trp at 30
oC .   C u l t u r e s  w e r e  r e i n o c u l a t e d  i n  S C  r a f  
minus Trp and grown at 30°C to early log phase (A600 of 
~0.5).  Cultures were then reinnoculated at OD0.05 in 
media containing 2% gal and their growth was followed 
by measuring absorbance at the indicated time intervals.   
 
Cell cycle distribution of WRN transformed sgs1 top3 
strain.  Logarithmically growing cultures of sgs1 top3 
transformed with YEp112SpGAL, YEp112SpGAL–
WRN,  or YEp112SpGAL–SGS1, and the vector-
transformed wild-type parental strain were induced at 
2% gal concentration for 6 h.  For DAPI (4', 6-
diamidino-2-phenylindole) staining, 70% ethanol
 fixed 
cells were washed with phosphate-buffered saline 
(PBS), stained and mounted in
  Vectashield mounting 
medium with DAPI (1  µg/ml) (Vector,
  USA).  Cells 
were examined with an Axiovert 200  M microscope
 
(Zeiss; 100x lens) and composite differential inter-
ference contrast
  (DIC) and fluorescence images were 
analyzed using AxioVision,
  version 3.0 program 
(Zeiss). 
 
Western blot analyses.  Transformed sgs1 or sgs1 top3 
strains were grown in SC raf minus Trp at 30
oC to an 
OD600 of 0.5.  Cultures were then induced at the 
indicated gal concentration for 6 h.  Cells (3 ml) were 
collected by centrifugation, washed with PBS, lysed in 
alkaline lysis buffer [50 mM NaOH, pH 10.5, 2 mM 
EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), 
2% SDS, 10% glycerol, 5% 2-mercaptoethanol and 
protease inhibitors (Roche Molecular Biochemicals)], 
boiled for 5 min, clarified by centrifugation, and 
neutralized with 1 M HCl.  Proteins from equivalent 
amounts of cell lysate were resolved on 8-16% 
polyacrylamide SDS gels.  Expression of WRN or 
WRN mutant proteins was determined by Western blot 
using a WRN mouse monoclonal antibody directed 
against an epitope in a purified C-terminal fragment of 
WRN [47] (1:1000, Spring Valley Labs).  For quan-
titative Western blot analysis, increasing concentrations 
of purified recombinant His-tagged full-length WRN 
protein were included on gels with yeast lysate samples.                       12. Harmon  FG,  DiGate  RJ,  Kowalczykowski  SC.  RecQ  helicase 
and  topoisomerase  III  comprise  a  novel  DNA  strand  passage 
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Wild  type  parental  strain  W303‐1A  transformed  with  YEp112SpGAL,  YEp112SpGAL–WRN,  exonuclease‐dead




   












































































Supp.  Data  Figure  3.  WRN  expression  has  no  effect  on  the  growth  rate  of  sgs1  strain.  sgs1  strain
transformed  with  YEp112SpGAL,  YEp112SpGAL–WRN,  exonuclease‐dead  (YEp195SpGAL‐WRN  E84A),
ATPase/helicase‐dead  (YEp195SpGAL–WRN  K577M),  RQC  mutant  (YEp195SpGAL‐WRN  K1016A)  and  polymorphic
mutant (YEp195SpGAL‐WRN R834C) was streaked on SC‐Trp plate containing either 2% glu (Panel B) or gal at varying






























   








    
           Supp. Data Table 1.  Oligonucleotides used for WRN site‐directed mutagenesis 
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